Stay updated on THALES: TicAgrelor & ASA in Acute Stroke Clinical Trial
Sign up to get notified when there's something new on the THALES: TicAgrelor & ASA in Acute Stroke Clinical Trial page.

Latest updates to the THALES: TicAgrelor & ASA in Acute Stroke Clinical Trial page
- Check4 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study record content with a generic error view. This indicates an access issue rather than a content update.SummaryDifference15%

- Check11 days agoChange DetectedA new revision label v3.7.0 was added. The previous revision label v3.6.6 was removed.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page shows a new revision label, updating from v3.6.5 to v3.6.6, which indicates a minor update to the page or its underlying system. This change does not introduce any visible content changes to the user.SummaryDifference0.0%

- Check32 days agoChange DetectedThe study identifiers section now includes '2016 ( U.S. NIH Grant/Contract )', indicating NIH funding for the THALES trial. This addition does not modify the study content or how a user would interact with the page.SummaryDifference0.0%

- Check46 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5. This represents a minor update to the page's documentation/version tracking rather than substantive content changes.SummaryDifference0.0%

- Check60 days agoChange DetectedThe study location entry for Zaporizhzhia is updated to Zaporizhzhya with two site codes (69068 and 69600), replacing the previous spelling. The page revision is updated from v3.6.3 to v3.6.4.SummaryDifference0.0%

Stay in the know with updates to THALES: TicAgrelor & ASA in Acute Stroke Clinical Trial
Enter your email address, and we'll notify you when there's something new on the THALES: TicAgrelor & ASA in Acute Stroke Clinical Trial page.